Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT07054320
Eligibility Criteria:
Inclusion Criteria:
* Male or Female Adults, 18 years and older
* Females of child-bearing age taking birth control medication
* Received a Hoskinson Health and Wellness Clinic physician prescription for Rapamune (Sirolimus)
Exclusion Criteria:
* Adults requiring monoclonal antibody or biological treatment
* Adults diagnosed with an acute lower respiratory or GI infection within 2 weeks
* Adults females who are not taking birth control medication, are pregnant or nursing mothers
* Adults reporting severe mental or physical disability
* Adults reporting unwillingness to travel to onsite clinical facilities
* Adults with any change in chronic disease symptoms or medication within 3 months
* Any contraindications to medical treatment with Rapamune (Sirolimus), as outlined in the FDA-approved medication guide
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07054320
Study Brief:
Protocol Section:
NCT07054320